An Orally Bioavailable C-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth

Anti-Cancer Agents in Medicinal Chemistry - United Arab Emirates
doi 10.2174/1871520611009010028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology

English

The HSP90 Inhibitor Ganetespib Synergizes With the MET Kinase Inhibitor Crizotinib in Both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models

Cancer Research
Cancer ResearchOncology
2013English

A Recombinant Chimeric Protein Specifically Induces Mutant KRAS Degradation and Potently Inhibits Pancreatic Tumor Growth

Oncotarget
Oncology
2016English

PCC0208027, a Novel Tyrosine Kinase Inhibitor, Inhibits Tumor Growth of NSCLC by Targeting EGFR and HER2 Aberrations

Scientific Reports
Multidisciplinary
2019English

Hematein, a Casein Kinase II Inhibitor, Inhibits Lung Cancer Tumor Growth in a Murine Xenograft Model

International Journal of Oncology
Cancer ResearchOncology
2013English

A Selective C-Met and TRKS Inhibitor Indo5 Suppresses Hepatocellular Carcinoma Growth

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2019English

Met Tyrosine Kinase Inhibitor, PF-2341066, Suppresses Growth and Invasion of Nasopharyngeal Carcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable Γ-Secretase Inhibitor

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2010English

GSK1838705A, an IGF-1R Inhibitor, Inhibits Glioma Cell Proliferation and Suppresses Tumor Growth in Vivo

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy